CD8A and neoplasm: Both a subcutaneous and a metastatic model, generated via intravenous injection of MB49 tumor cells, were taken into consideration and a reduction of tumor volume and increased mouse survival were reported, together with an increase in the frequency of CD8+ T cells in the spleens and in the tumor-draining lymph nodes of both models.